0001209191-23-002894.txt : 20230110
0001209191-23-002894.hdr.sgml : 20230110
20230110202010
ACCESSION NUMBER: 0001209191-23-002894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230106
FILED AS OF DATE: 20230110
DATE AS OF CHANGE: 20230110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIM AUSTIN D.
CENTRAL INDEX KEY: 0001746240
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 23522355
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-06
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001746240
KIM AUSTIN D.
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
EVP,General Counsel, Secretary
Common Stock
2023-01-06
4
M
0
1633
A
19286
D
Common Stock
2023-01-09
4
S
0
589
17.1303
D
18697
D
Restricted Stock Units
2023-01-06
4
M
0
1633
0.00
D
Common Stock
1633
1634
D
Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
Includes 911 shares of the Issuer's common stock acquired by the reporting person on May 16, 2022 pursuant to an employee stock purchase program.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.13 to $17.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The restricted stock units vest in four equal annual installments beginning January 6, 2021.
/s/ Austin D. Kim
2023-01-10